6 reasons why you should sell Coca-Cola Amatil Ltd

While many analysts have stated that Coca-Cola Amatil is currently the "buy of a lifetime", the company's best days may be behind it.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Following a profit downgrade and strategic review in April, the share price of Coca-Cola Amatil Ltd (ASX: CCL) was smashed and has not yet recovered. Many analysts have stated that the market over-reacted and the current share price of $9.41 represents a once in a lifetime buying opportunity. However, for the reasons outlined below, I believe Coca-Cola Amatil is facing structural headwinds and further earnings downgrades are likely.

1.The current price war with Asahi/Schweppes has significantly impacted recent earnings and will continue to negatively impact earnings over the medium term.

2. Indonesia has been the main growth driver of earnings over recent years, however growth will likely normalise in Indonesia over coming years as Coca-Cola Amatil continues to lose market share to low-priced competitors in the region which have significantly lower cost bases.

3 While bottled water is a key growth area for the business, the company has had trouble differentiating the Coca-Cola brand and therefore incorporating a price premium.

4. Price competition in the Australian supermarket channel is still strong, with the dominant Woolworths Limited (ASX:WOW) and Coles continuing to heavily discount. Discounting by Australia's largest two supermarkets shows no signs of easing over the medium term as they continue to exert their dominance.

5. Health trends in Australia are increasingly shifting demand away from traditional "unhealthy" carbonated soft drinks, such as Coke, and towards bottled water and other beverages with a greater perceived health value.

6. Coca-Cola Amatil's cost base is too high and needs to be lowered to match its lower growth outlook. This combined with an unprecedented level of quality competition, and over-reliance on price increases to drive earnings growth over the past decade, creates further downside risk.

Motley Fool contributor Bradley Murphy owns shares in Woolworths mentioned in this article. 

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »